C. Jommi and R. Ravasio, “The value of obinutuzumab for untreated advanced Follicular Lymphoma: an assessment based on Multicriteria Decision Analysis (MCDA)”, AboutOpen, vol. 6, no. 1, pp. 78–85, Nov. 2019.